DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20212532

Priapism as the initial manifestation of chronic myeloid leukemia, a rare presentation

Regina de Miguel-Ibañez, Marcos Daniel Sanchez-Gonzalez, Diana Arlett Herrera-Madrid

Abstract


Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm with a median age of diagnosis in Mexico of 40 years. The initial manifestations are varied; however, priapism is a very rare entity associated to CML. We report the case of an 18-year-old male with an 8-hour episode of ischemic priapism managed with cavernous lavage, achieving complete flaccidity of the penis. The patient was diagnosed with CML, initiating cytoreduction with hydroxycarbamide and after having molecular confirmation, we started treatment with a tyrosine kinase inhibitor. The patient was discharged in excellent conditions, without sequelae of erectile dysfunction, all this attributed to the time of evolution, the adequate management of the urological emergency and the prompt identification and treatment of the precipitating condition.


Keywords


Leukemia, Myelogenous, Chronic, BCR-ABL positive, Protein kinase inhibitors, Priapism

Full Text:

PDF

References


Hochhaus A, Saussele S, Rosti G, Mahon FX, Janssen JJWM, Hjorth-Hansen H, et. al. ESMO Guidelines Committee. Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(4):iv41-51.

Apperley JF. Chronic myeloid leukaemia. Lancet. 2015;385(9976):1447-59.

Alvarado-Ibarra M, Cardiel-Silva M, García-Camacho A, González-González L et. al. Consensus on chronic myelogenous leukemia by hematologists of the ISSSTE. Rev Hematol Mex. 2016;17(1):34-62.

Hochhaus A, Baccarani M, Silver RT. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia. 2020;34:966-84.

Santoyo A, Ramos C, Saavedra A. Age and gender frequencies of patients with leukemia observed in two reference centers in the Valley of Mexico. Gac Med Mex. 2016;152:208-12.

Rodgers R, Latif Z, Copland M. How I manage priapism in chronic myeloid leukaemia patients. Br J Haematol. 2012;158(2):155-64.

Salonia A, Eardley I, Giuliano F, Hatzichristou D, Moncada I, Vardi Y, et al. European Association of Urology. European Association of Urology guidelines on priapism. Eur Urol. 2014;65(2):480-9.

Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, et. al; Members of the Erectile Dysfunction Guideline Update Panel; Americal Urological Association. American Urological Association guideline on the management of priapism. J Urol. 2003;170 (4 Pt 1):1318-24.